Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(11):858; doi:10.1093/jnci/dji147
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Popat, S.
Right arrow Articles by Smith, I. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popat, S.
Right arrow Articles by Smith, I. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis

Sanjay Popat, Ian E. Smith

Affiliations of authors: Breast Unit, Royal Marsden Hospital, London SW3 6JJ

Correspondence to: Sanjay Popat, Breast Unit, Royal Marsden Hospital, London SW3 6JJ, England (e-mail: sanjay.popat@icr.ac.uk).

The first 10% of the full text of this article appears below.

The meta-analysis by Mauri et al. (1) from nine neoadjuvant trials is important given the conflicting evidence from published studies. However, we would like to make . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?